Mealey's (September 29, 2020, 2:45 PM EDT) -- SAN FRANCISCO — A pharmacy chain accused in a putative class complaint of violating California laws, including the unfair competition law (UCL), charging more for fever and pain medicine labeled for infants than the same product labeled for children, showed that the amount in controversy exceeds the Class Action Fairness Act's (CAFA) $5 million threshold, a federal magistrate judge in California ruled Sept. 17 (Danielle Lokey v. CVS Pharmacy, Inc., No. 20-4782, N.D. Calif., 2020 U.S. Dist. LEXIS 170690)....